StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$0.45+0.02 (+4.90%)

Close on Nov 18, 2026Market cap $6.88MP/E –Yield –

Dare Bioscience revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Dare Bioscience's revenue for the twelve months ending Jun 30, 2026 was $1.37M. For fiscal 2025 it was $1.03M, up 10429.4% from the year before. The highest annual figure on record is $10.00M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.03M+10429.4%
FY2024Dec 31, 2024$9.78K-99.7%
FY2023Dec 31, 2023$2.81M-71.9%
FY2022Dec 31, 2022$10.00M–
FY2021Dec 31, 2021$0-100.0%
FY2016Dec 31, 2016$766.00K+857.5%
FY2014Dec 31, 2014$80.00K+1233.3%
FY2013Dec 31, 2013$6.00K-99.0%
FY2012Dec 31, 2012$625.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$187.55K+637.6%
Q1 FY2026Mar 31, 2026$152.46K+265.7%
Q4 FY2025Dec 31, 2025$1.02M+4462.2%
Q3 FY2025Sep 30, 2025$2.26K-75.7%
Q1 FY2025Mar 31, 2025$25.43K-98.6%
Q3 FY2024Sep 30, 2024$41.69K-95.8%
Q2 FY2024Jun 30, 2024$22.44K–
Q1 FY2024Mar 31, 2024$9.30K–
Q4 FY2023Dec 31, 2023$1.81M–
Q3 FY2023Sep 30, 2023$1.00M–
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$0–
Q4 FY2022Dec 31, 2022$0–
Q3 FY2022Sep 30, 2022$0–
Q2 FY2022Jun 30, 2022$10.00M+1457.6%
Q4 FY2021Dec 31, 2021$0-100.0%
Q3 FY2021Sep 30, 2021$0-100.0%
Q2 FY2021Jun 30, 2021$0–
Q2 FY2017Jun 30, 2017$642.00K–
Q1 FY2017Mar 31, 2017$1.19M–
Q4 FY2016Dec 31, 2016$766.00K–

More Dare Bioscience figures

See a number that looks wrong?